Risk aversion and COVID-19 vaccine hesitancy

Anthony Lepinteur; Liyousew G. Borga; Andrew E. Clark; Claus Vögele; Conchita D’Ambrosio

doi:10.1002/hec.4693

Risk aversion and COVID-19 vaccine hesitancy

Anthony Lepinteur^*
, Liyousew G. Borga
, Andrew E. Clark
, Claus Vögele
, Conchita D’Ambrosio

^*Corresponding author for this work

Digital Medicine

Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)

Abstract

We here investigate the role of risk aversion in COVID-19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID-19 infection and vaccination side-effects involve probabilistic elements. In large-scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID-19 infection is perceived as involving greater risk than is vaccination.

Original language	English
Pages (from-to)	1659-1669
Number of pages	11
Journal	Health Economics (United Kingdom)
Volume	32
Issue number	8
Early online date	5 May 2023
DOIs	https://doi.org/10.1002/hec.4693
Publication status	Published - Aug 2023

Keywords

COME-HERE survey
Europe
risk aversion
vaccine hesitancy

Access to Document

10.1002/hec.4693Licence: CC BY

Cite this

@article{b923a721d7234b4087e9ed9c57d1e791,

title = "Risk aversion and COVID-19 vaccine hesitancy",

abstract = "We here investigate the role of risk aversion in COVID-19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID-19 infection and vaccination side-effects involve probabilistic elements. In large-scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID-19 infection is perceived as involving greater risk than is vaccination.",

keywords = "COME-HERE survey, Europe, risk aversion, vaccine hesitancy",

author = "Anthony Lepinteur and Borga, \{Liyousew G.\} and Clark, \{Andrew E.\} and Claus V{\"o}gele and Conchita D{\textquoteright}Ambrosio",

note = "Funding Information: Andrew Clark acknowledges financial support from the EUR grant ANR‐17‐EURE‐0001. All authors thank the French Agence Nationale de la Recherche (ANR‐21‐CO16‐0002), Andr{\'e} Losch Fondation, Art2Cure, Cargolux, CINVEN Foundation and COVID‐19 Foundation, under the aegis of the Fondation de Luxembourg, and the Fonds National de la Recherche Luxembourg (Grant 14840950—COME‐HERE) for generous funding. Publisher Copyright: {\textcopyright} 2023 The Authors. Health Economics published by John Wiley \& Sons Ltd.",

year = "2023",

month = aug,

doi = "10.1002/hec.4693",

language = "English",

volume = "32",

pages = "1659--1669",

journal = "Health Economics (United Kingdom)",

issn = "1057-9230",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

TY - JOUR

T1 - Risk aversion and COVID-19 vaccine hesitancy

AU - Lepinteur, Anthony

AU - Borga, Liyousew G.

AU - Clark, Andrew E.

AU - Vögele, Claus

AU - D’Ambrosio, Conchita

N1 - Funding Information: Andrew Clark acknowledges financial support from the EUR grant ANR‐17‐EURE‐0001. All authors thank the French Agence Nationale de la Recherche (ANR‐21‐CO16‐0002), André Losch Fondation, Art2Cure, Cargolux, CINVEN Foundation and COVID‐19 Foundation, under the aegis of the Fondation de Luxembourg, and the Fonds National de la Recherche Luxembourg (Grant 14840950—COME‐HERE) for generous funding. Publisher Copyright: © 2023 The Authors. Health Economics published by John Wiley & Sons Ltd.

PY - 2023/8

Y1 - 2023/8

N2 - We here investigate the role of risk aversion in COVID-19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID-19 infection and vaccination side-effects involve probabilistic elements. In large-scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID-19 infection is perceived as involving greater risk than is vaccination.

AB - We here investigate the role of risk aversion in COVID-19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID-19 infection and vaccination side-effects involve probabilistic elements. In large-scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID-19 infection is perceived as involving greater risk than is vaccination.

KW - COME-HERE survey

KW - Europe

KW - risk aversion

KW - vaccine hesitancy

UR - https://www.scopus.com/pages/publications/85158087627

UR - https://pubmed.ncbi.nlm.nih.gov/37146156

U2 - 10.1002/hec.4693

DO - 10.1002/hec.4693

M3 - Article

C2 - 37146156

AN - SCOPUS:85158087627

SN - 1057-9230

VL - 32

SP - 1659

EP - 1669

JO - Health Economics (United Kingdom)

JF - Health Economics (United Kingdom)

IS - 8

ER -

Risk aversion and COVID-19 vaccine hesitancy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this